Figure 4
- ID
- ZDB-FIG-230228-177
- Publication
- Le Mentec et al., 2023 - A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation
- Other Figures
- All Figure Page
- Back to All Figure Page
Screening of the steatogenic molecules and validation of the steatogenic effect with the StAZ using the transgenic zebrafish model. Zebrafish transgenic larvae at 3 days post-fertilization were exposed to positive control steatogenic conditions (HFD, ethanol, amiodarone, valproate, TCDD) ( |